Literature DB >> 15972278

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases.

L Albiges, F André, C Balleyguier, G Gomez-Abuin, A Chompret, S Delaloge.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15972278     DOI： 10.1093/annonc/mdi351

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  27 in total

1.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.

Authors:  S Bayraktar; A M Gutierrez-Barrera; H Lin; N Elsayegh; T Tasbas; J K Litton; N K Ibrahim; P K Morrow; M Green; V Valero; D J Booser; G N Hortobagyi; B K Arun
Journal:  Clin Exp Metastasis       Date:  2013-02-01       Impact factor: 5.150

3.  Inverse spatial distribution of brain metastases and white matter hyperintensities in advanced lung and non-lung cancer patients.

Authors:  Carlo Cosimo Quattrocchi; Yuri Errante; Carlo Augusto Mallio; Luciano Carideo; Laura Scarciolla; Daniele Santini; Giuseppe Tonini; Bruno Beomonte Zobel
Journal:  J Neurooncol       Date:  2014-07-22       Impact factor: 4.130

4.  Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases' occurrence.

Authors:  Imen Medimegh; Wafa Troudi; Nejla Stambouli; Houssein Khodjet-El-Khil; Olfa Baroudi; Hajer Ayari; Ines Omrane; Nancy Uhrhammer; Maud Privat; Amel Mezlini; Farhat Ben Ayed; Khaled Ben Romdhane; Sylvie Mader; Yve Jean Bignon; Amel Benammar Elgaaied
Journal:  Med Oncol       Date:  2014-10-02       Impact factor: 3.064

Review 5.  Mouse models of advanced spontaneous metastasis for experimental therapeutics.

Authors:  Giulio Francia; William Cruz-Munoz; Shan Man; Ping Xu; Robert S Kerbel
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 6.  CNS complications of breast cancer: current and emerging treatment options.

Authors:  Evert C A Kaal; Charles J Vecht
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Integrative analysis of two cell lines derived from a non-small-lung cancer patient--a panomics approach.

Authors:  Oleg Mayba; Florian Gnad; Michael Peyton; Fan Zhang; Kimberly Walter; Pan Du; Melanie A Huntley; Zhaoshi Jiang; Jinfeng Liu; Peter M Haverty; Robert C Gentleman; Ruiqiang Li; John D Minna; Yingrui Li; David S Shames; Zemin Zhang
Journal:  Pac Symp Biocomput       Date:  2014

8.  Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.

Authors:  Nancy U Lin; Elizabeth Claus; Jessica Sohl; Abdul R Razzak; Amal Arnaout; Eric P Winer
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 9.  Current therapeutic options for breast cancer central nervous system metastases.

Authors:  M Brian Hemphill; Julia A Lawrence
Journal:  Curr Treat Options Oncol       Date:  2008-04-05

10.  A nomogram for predicting brain metastasis in patients with de novo stage IV breast cancer.

Authors:  Ming-Shuai Sun; Yin-Hua Liu; Jing-Ming Ye; Qian Liu; Yuan-Jia Cheng; Ling Xin; Ling Xu
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.